What amount sold does Canaria Therapeutics, Inc. report in Form D filings?

The latest linked filings report $25K sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Canaria Therapeutics, Inc.'s most recent SEC filing?

Canaria Therapeutics, Inc.'s most recent Form D filing was on 2021-06-02.

How many investors does Canaria Therapeutics, Inc. have?

The most recent Form D filing lists 12 investor(s).

What type of securities does Canaria Therapeutics, Inc. offer?

Canaria Therapeutics, Inc.'s SEC Form D filings indicate equity offerings.

Canaria Therapeutics, Inc.

CIK: 0001754404·Biotechnology·HUNTSVILLE, AL·Corporation·Founded 2018

Reported Sold

$24,611

Total Filings

Identified Offerings

Last Filed

Jun 2, 2021

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jun 2, 2021Form D/A — Amendment

Reported sold: $2,832 · Target: $23,100

Rule 506(b)·12 investors

Changed: Reported amount sold

Jun 10, 2020Form D/A — Amendment

Reported sold: $2,755 · Target: $23,100

Rule 506(b)·12 investors

Changed: Reported amount sold, Reported investors

Mar 4, 2020Form D/A — Amendment

Reported sold: $2,732 · Target: $23,100

Rule 506(b)·11 investors

Changed: Reported amount sold, Offering target, Reported investors

Jul 2, 2019Form D — New notice

Reported sold: $76 · Target: $5,000

Rule 506(b)·1 investor

Oct 24, 2018Form D — New notice

Reported sold: $21,779 · Target: $29,536

Rule 506(b)·36 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

60%

Latest reported sold across 2 identified offerings

$24,611

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

J Milton Harris

Related Person

Appears on 5 filings

Randall W Moreadith

Related Person

Appears on 5 filings

Barbara Fisk

Related Person

Appears on 5 filings

Michael D Bentley

Related Person

Appears on 5 filings

James R Hudson, Jr.

Related Person

Appears on 5 filings

Miguel A Loya

Related Person

Appears on 5 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Jun 2, 2021	Amendment	$23,100	$2,832	12
Jun 10, 2020	Amendment	$23,100	$2,755	12
Mar 4, 2020	Amendment	$23,100	$2,732	11
Jul 2, 2019	New	$5,000	$76	1
Oct 24, 2018	New	$29,536	$21,779	36

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Monocacy Therapeutics Inc.

Biotechnology

Offering target: $25,000

Filed Oct 7, 2026